Attached Carole Ho - 05 Aug 2025 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Signature
/s/ Tyler Nielsen, by power of attorney
Issuer symbol
DNLI
Transactions as of
05 Aug 2025
Net transactions value
+$30,365
Form type
4
Filing time
07 Aug 2025, 17:34:32 UTC
Previous filing
31 Jul 2025
Next filing
14 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ho Carole Chief Medical Officer C/O DENALI THERAPEUTICS INC., 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO /s/ Tyler Nielsen, by power of attorney 07 Aug 2025 0001724605

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Options Exercise $30,365 +44,655 +25% $0.6800 220,328 05 Aug 2025 Direct F1
holding DNLI Common Stock 183,219 05 Aug 2025 See footnote F2
holding DNLI Common Stock 25,000 05 Aug 2025 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNLI Stock Option (right to buy) Options Exercise $0 -44,655 -42% $0.000000 62,500 05 Aug 2025 Common Stock 44,655 $0.6800 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 134,030 Unvested RSUs.
F2 The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
F3 The shares are held of record by The Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.
F4 The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days.